CellType Inc.
CellType operates as an agentic drug company that simulates human biology using a biological world model. The company develops foundation models trained on human cellular and molecular data to predict drug response, toxicity, patient variation, and diagnostics.
Where CellType Inc. ranks
Current edition · updated Oct 20, 2026About CellType Inc.
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
Products
A suite of services built on the CT-1 foundation model, offering translational biology, patient signal connection, and virtual experiments for drug development.
A paid offering that enables the CellType Agent to submit jobs to CellType Cloud, a hosted GPU compute service for running managed tools on CellType-managed infrastructure.
An open-source CLI tool for local use.
The underlying hosted compute service that processes biological data, prompts, and queries submitted via Agent Pro.
Security and compliance
As reported by CellType Inc.. Ask for audit reports before you buy.
- CCPA/CPRACompliant
- Data encryption in transit and at rest (implied by technical measures)
- Access controls
- Administrative safeguards
- Organizational safeguards
- Technical safeguards
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim CellType Inc.